Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases
Description
Chronic liver disease (CLD) entails elevated risk of COVID-19 severity and mortality. The effectiveness of the booster dose of inactivated SARS-CoV-2 vaccine in stimulating antibody response in CLD patients is unclear. Therefore, we conducted a cross
